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O B J E C T I V E S We sought to test the hypothesis that measures of left atrial (LA) function are
independent predictors of mortality in patients with acute myocardial infarction.
B A C KG ROUND Left atrial maximal volume (LAmax) is known to predict mortality in patients with
acute myocardial infarction. In a previous pilot study, however, we found that LA function in terms of
fractional change and left atrial ejection fraction (LAEF) assessed by multidetector computed tomogra-
phy (MDCT) is more closely related to clinical heart failure than LAmax.
METHOD S We prospectively included 384 patients presenting with non–ST-segment elevation
myocardial infarction (NSTEMI) who underwent retrospectively gated, 64-slice MDCT coronary angiog-
raphy and subsequent measurements of LA size and function. All patients were treated according to the
current guidelines based on invasive coronary angiography. Patients were followed for a minimum of 2
years. The study endpoint was all-cause mortality.
R E S U L T S The median follow-up time was 36 months (range 10 to 1,551 days). During follow-up, 35
(9%) patients died. Overall, 1- and 2-year survival in the study cohort was 97% and 94%. LA size and
mechanical function was obtained in all patients: mean LAmax was 55  11 ml/m2, LA minimal volume
31  11 ml/m2, fractional change 45  9%, and LAEF 32  9%. Using a Cox proportional hazards model
with adjustments for age, number of diseased coronary vessels, left ventricular ejection fraction (LVEF),
and Killip class, both fractional change (hazard ratio [HR]: 0.65; 95% conﬁdence interval [CI]: 0.45 to 0.94)
and LAEF (HR: 0.63; 95% CI: 0.44 to 0.91) remained independent predictors of mortality. In contrast to
this, LAmax was not signiﬁcantly associated with an increased risk of mortality in this population.
CONC L U S I O N S In a low-risk group of patients with NSTEMI, reduced LA function is an
independent predictor of mortality and provides prognostic value incremental to that of LAmax. (J Am
Coll Cardiol Img 2011;4:1080–7) © 2011 by the American College of Cardiology Foundation
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he left atrium (LA) acts as a reservoir and
conveys blood from the pulmonary vascular
bed to the left ventricle. The left atrial maxi-
mal volume (LAmax) is determined by mul-
iple factors, including the pressure gradient across
he mitral valve in early diastole, left ventricular
LV) chamber compliance, LA active contraction,
nd intrinsic LA wall factors. It is believed that the
A will dilate in response to either volume or
ressure overload (1–3). In agreement with this,
everal studies have demonstrated that LA dilation
s associated with increased morbidity and mortality
n patients with acute myocardial infarction and
ardiomyopathy (4–6). However, the LA modu-
ates blood flow to the left ventricle in a complex
anner, and measurements of LAmax may only
artially reflect the prognostic implications of volume
r pressure overload of the chamber. Multidetector
omputed tomography (MDCT) with high spatial
nd temporal resolution has been shown to be suitable
or a more elaborate description of LA function (7,8).
We have recently reported that LA fractional
hange (difference between maximal and minimal
A volume) and left atrial ejection fraction (LAEF)
ere more closely related to clinical signs of heart
ailure than LAmax measured with MDCT in a
roup of patients with coronary artery disease (8). Based
n this observation, we hypothesized that decreased LA
unction assessed with MDCT is an independent pre-
ictor of adverse outcome in patients with acute coronary
rtery disease, and is incremental to LAmax.
In the current study, we therefore tested the hy-
othesis that MDCT measures of LA function pre-
ict outcome in patients with a recent non–ST-
egment elevation myocardial infarction (NSTEMI).
M E T H O D S
Between December 2006 and January 2009, consec-
utive patients (n 1,409) with NSTEMI, referred for
invasive coronary angiography at Copenhagen Uni-
versity Hospital Rigshospitalet, were screened for
participation in the study. NSTEMI was defined
according to guidelines (9) as symptoms with acute
hest pain and/or electrocardiographic changes with-
ut persistent ST-segment elevation and with a char-
cteristic rise and fall in serum troponin T. Patients were
canned with MDCT prior to the invasive procedure as
art of a research project. Patients with contraindication
o MDCT, history of chronic renal disease or elevated
lasma creatinine (125 mol/l, n  157), history of
atrial arrhythmias or arrhythmia during MDCT (n 
59), known allergy to iodine contrast (n 5), hemody- anamic instability (n  18), mitral insufficiency (n  7),
and refusal to participate (n 76), were not enrolled in
the study. Due to logistical reasons, 699 patients were not
enrolled, primarily due to absence of scanner availability
or coincidence with the invasive procedure. After enrol-
ment of 388 patients, 4 had to be excluded because they
could not be in follow-up due to nonresidency. Accord-
ingly, the final study population consisted of 384 patients
(Fig. 1). The study was approved by the local ethics
committee, and informed consent was obtained from all
patients.
MDCT and invasive coronary angiography were
performed in all included patients. Treatment strat-
egy was decided by the interventional cardiologist
according to international guidelines, blinded to
MDCT findings (9).
Previous medical history and cardiovascular risk profile
of the patients was recorded from hospital
charts. Clinical signs of heart failure within 5
days prior to MDCT were recorded according
to the Killip class.
The endpoint of the study was death
from all causes. Vital status of included
patients was recorded for a minimum of 2
years after inclusion from electronic data-
bases containing vital status in Denmark
(Green System, CSC Scandihealth) and
the Faroe Islands (Cambio COSMIC reg-
istry).
Multidetector computed tomography. All
patients were scanned using a 64-slice
MDCT scanner (Toshiba Aquillion,
Toshiba Medical Systems Corporation,
Otawara, Japan) prior to angiography
and/or intervention with the following
parameter settings: tube voltage 120 to
135 kV depending on body mass index,
detector collimation 64  0.5 mm, and rotation
ime between 350 ms and 500 ms depending on the
eart rate. Depending on expected scan time, 70 to
00 ml of contrast agent (Visipaque 320, GE
ealthcare, Chalfont St. Giles, United Kingdom)
as infused with a rate of 5 ml/s, followed by 30 ml
f 70:30 (%) contrast/saline mix, and then 30 ml of
ure saline chaser. Image acquisition was initiated
y automatic bolus triggering. The estimated radi-
tion dose was 14 to 20 mSv with use of retrospec-
ive gating and dose modulation. Raw data were
econstructed in 5% intervals throughout the car-
iac cycle, with a slice thickness and increment of
.0/2.0 mm. No additional beta-blocker or other
edication was administered prior to MDCT ex-
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1082external workstation (Vitrea 2, version 4.0, Vital
Images Inc, Minnetonka, Minnesota) for image
analysis blinded to clinical information.
Image analysis. LA volumes were measured as pre-
viously described (8), by tracing the endocardial
border on 15 to 20 tomographic slices—depending on
size and shape of the chamber—using axial view
images. The pulmonary veins were carefully excluded,
whereas the LA appendage was included in the LA
cavity. The software interpolated the endocardial seg-
mentation to calculate the volume. Volumes were
measured in 5% intervals during the RR cycle, and a
time–volume plot was generated for each patient.
LA reservoir function was assessed as cyclic
change (CC) (calculated as the difference between
LAmax and left atrial minimal volume [LAmin])
and fractional change (calculated as CC/LAmax).
LA passive emptying was assessed as reservoir
volume (calculated as the difference between
LAmax and the minimal mid-diastolic volume;
defined as the lowest point between LAmax and
“the LA volume immediately before atrial systole”)
and reservoir fraction (reservoir volume/LAmax).
LA active emptying was assessed as left atrial stroke
volume (LASV) (defined as the difference between
“LA volume immediately before atrial systole” and
LAmin) and LAEF (LAEF  LASV/“LA volume
ust before atrial systole”).
Interobserver variability was assessed in 50 pa-
ients. Mean percentage error of LAmin was 1 
1%, of LAmax 3  9%, of fractional change 5 
1%, and of LAEF 2  19%. At our center,
greement between assessment of LA size and
Figure 1. Flow Chart of Patient Inclusion
Flow chart of patient inclusion, with reasons for exclusion and tota
computed tomography.unction between cardiac magnetic resonance im-ging and MDCT has been assessed in 50 patients
ith ischemic heart disease. Mean percentage error
as: LAmin 4  14%, LAmax 9  12%, fractional
hange 2  13%, and LAEF 3  20% (10).
LV end-diastolic volume, LV end-systolic vol-
me, and left ventricular ejection fraction (LVEF)
ere measured as previously described (11).
Statistics. Statistical analysis was performed using
SAS version 9.13 (SAS Institute, Cary, North
Carolina). Continuous variables are presented as
mean  SD and categorical variables as frequencies
and percentages. For statistical comparisons, a
2-tailed t test for independent samples was used for
continuous values and chi-square test was used for
categorical variables. Continuous variables that
were not normally distributed were compared with
Mann-Whitney U test. Chi-square test for trend
was used to test differences between ordered groups.
The relation between mortality and tertiles of
LAmax, LAmin, fractional change, and LAEF
was plotted according to the Kaplan-Meier
method, and death rates were compared by the
log-rank test. The relationship between MDCT
variables, clinical variables, and all-cause mortal-
ity was assessed using Cox proportional hazards
regression. First, a univariable analysis was per-
formed for potential LA predictors of clinical
events: LAmax, LAmin, fractional change, CC,
reservoir volume, reservoir fraction, LAEF, LASV,
and in addition, for age, sex, hypertension, LVEF,
number of diseased coronary vessels, Killip class,
diabetes, and previous myocardial infarction. Second,
multivariable regression analysis with forced entry of
ber of patients in the study population. MDCT  multidetectorl numLAmax, LAmin, fractional change, CC, LAEF, and
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1083LASV was performed separately with adjustment for
established clinical predictors (age, LVEF, number of
diseased vessels, and Killip class 2). Finally, the
overall Wald chi-square of a model including LAmax,
age, LVEF, number of diseased vessels, and Killip
class 2 was compared with a model with the afore-
mentioned variables and either fractional change or
LAEF to assess the incremental information of LA
function. The proportional hazard assumption was
checked through the method of cumulative residuals.
The discriminative power of LA size and function
after 2 years of follow-up was assessed by calculating
the mean of the area under the receiver-operator
characteristic curve (AUC). A p value 0.05 was
onsidered statistically significant.
R E S U L T S
Demographic information of patients enrolled in
the study is given in Table 1. Patients screened for
participation in the study but not enrolled (n 
1,025) were older (67  12 years vs. 61  12 years,
p  0.001), had lower estimated glomerular filtra-
tion rate (76 38 ml/min vs. 87 20 ml/min, p
0.001), and were more likely to have diabetes (24%
Table 1. Demographics (n  384)
Age, yrs 61 12
Female 92 (24)
Body mass index, kg/m2 28 5
Hypertension 191 (50)
Diabetes 61 (16)
eGFR 87 20
Smoker (current or former) 285 (74)
Previous myocardial infarction 85 (23)
Coronary artery disease
No signiﬁcant stenosis 67 (17)
1-vessel disease 138 (36)
2-vessel disease 98 (26)
3-vessel disease 79 (21)
Left main disease 21 (5)
Left ventricular ejection fraction, % 58 12
Troponin T maximum, ng/ml 0.84 1.30
Killip class 2 45 (12)
Medication at discharge
Beta-blocker 319 (83)
ACE-inhibitor 107 (28)
AIIA 34 (9)
Aspirin 370 (96)
Clopidogrel 363 (95)
Statin 371 (97)
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; AIIA  angiotensin II receptor
antagonist; eGFR  estimated glomerular ﬁltration rate (calculated using the0Modiﬁcation of Diet in Renal Disease formula).vs. 16%, p  0.001) and 3-vessel disease (26% vs.
21%, p  0.03) than patients who were enrolled,
but did not differ with regard to other risk factors or
treatment strategy.
In all enrolled patients, LA size and function
could be assessed. Mean LAmax was 55  11
ml/m2, LAmin 31  11 ml/m2, fractional change
45  9%, and LAEF 32  9%.
In univariate regression analysis, LA volumes
were correlated with EDV index (LAmax:  
0.26, p 0.001, and LAmin:  0.22, p 0.001)
and inversely correlated with LA function (frac-
tional change:   0.08, p  0.001, LAEF:  
0.09, p  0.001).
All-cause mortality. The median follow-up time
was 36 months (range 10 to 1,551 days). During
follow-up, 35 (9%) patients died. Overall, 1- and
2-year survival in the study cohort was 97% and
94%, respectively, which was significantly higher
than the 1- and 2-year survival among patients
excluded from the study (89% and 84%, respec-
tively, p  0.001).
In the study cohort, surviving patients were
characterized by lower age, lower prevalence of
3-vessel or left main disease, higher LVEF, and
lower Killip class (Table 2). Mortality according to
tertiles of LA size and function is presented in
Figure 2. High LAmin was associated with poor
survival, whereas there was no significant difference
between LAmax tertiles using log-rank statistics.
Poor LA function (reduced fractional change and
LAEF) was associated with adverse outcome.
In a univariate Cox regression analysis, the sig-
nificant LA predictors of all-cause mortality were
LAmin, fractional change, CC, LAEF, and LASV
(Table 2). LAmax, LAmin, fractional change, CC,
LAEF, and LASV were separately included in
separate multivariate Cox regression models with
forced entry of a priori known predictors of mortality
including: age, LVEF, number of diseased vessels, and
Killip class2. In those models, fractional change, CC,
AEF, and LASV remained independent predictors of
ll-cause mortality, whereas LA size was no longer
ignificant (Table 3).
The overall Wald chi-square of a model including
Amax, age, Killip class, LVEF, and number of diseased
essels was 38.00. If fractional change was added to this
odel, the overall Wald chi-square was 43.20, and if
AEF was added to the model, the overall Wald
hi-square was 44.61, p  0.05 for difference.
Receiver-operator characteristic curves are dis-
layed in Figure 3. The AUC was 0.57 for LAmax,
.74 for fractional change, and 0.66 for LAEF. Only
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1084AUC for fractional change was significantly higher than
AUC for LAmax (p  0.018).
To determine whether the location of the infarct-
related region had any influence on the LA func-
Figure 2. Kaplan-Meier Plots
Table 2. Unadjusted Predictors of All-Cause Mortality
Survivor
(n  349)
All-Cau
(n
Age, yrs 60 12 7
Female 86 (25)
Hypertension 171 (49)
Diabetes 52 (15)
Previous myocardial infarction 74 (22)
Vessel disease (0, 1, 2, 3, or LM) 76 (22)* 1
Left ventricular ejection fraction, % 59 12 5
Troponin T maximum, ng/ml 0.8 1.2 1
Killip class 2 33 (9)
LA maximal volume index, ml/m2 55 11 5
LA minimal volume index, ml/m2 30 10 3
Fractional change, % 46 9 3
Cyclic change, ml/m2 25 5 2
Reservoir volume, ml/m2 11 4 1
Reservoir fraction, % 20 7 1
LA ejection fraction, % 33 8 2
LA stroke volume, ml/m2 14 4 1
Values are mean  SD or n (%). *3-vessel or left main stem (LM) disease.
CI  conﬁdence interval; HR  hazard ratio; LA  left atrial.Mortality in the study population stratiﬁed in tertiles of left atrial size ation, we made a subgroup analysis of 138 patients
with 1-vessel disease, and tested whether the culprit
location in the left anterior descending coronary
artery, left circumflex coronary artery, or right
Mortality
35) Wald HR 95% CI p Value
7 24 1.09 1.05–1.13 0.001
7) 1 1.50 0.63–3.60 0.33
7) 1 1.43 0.73–2.80 0.29
6) 3 1.86 0.87–3.97 0.11
2) 2 1.69 0.79–3.30 0.19
6)* 12 1.80 1.29–2.64 0.001
14 10 0.96 0.94–0.99 0.003
2.3 2 1.15 0.96–1.37 0.14
4) 19 4.40 2.17–8.77 0.001
14 2 1.02 0.99–1.05 0.12
15 16 1.05 1.02–1.07 0.001
11 29 0.92 0.90–0.95 0.001
5 18 0.90 0.85–0.95 0.001
3 1 0.95 0.95–1.04 0.28
6 3 0.11 0.01–1.84 0.10
10 22 0.92 0.89–0.95 0.001
4 11 0.85 0.78–0.93 0.001se

1
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1085coronary artery was associated with different values
for fractional change and LAEF; no difference
between the groups was noted (fractional change
p  0.47, LAEF p  0.17). We also made an
nalysis of the left anterior descending coronary
rtery versus non–left anterior descending coronary
rtery and found no difference between groups
fractional change p  0.43, LAEF p  0.22).
D I S C U S S I O N
To the best of our knowledge, this is the first study
that has investigated the prognostic information of
LA size and function assessed with MDCT in acute
coronary syndrome. The study suggests in a popu-
lation with NSTEMI that LA functional measures are
superior to LA size to predict outcome. This association
remained after adjustment for known risk factors of
outcome including age, LVEF, and Killip class.
LA size and function. During ventricular systole, the
endocardium undergoes significant radial displace-
ment, and as a result of contraction of longitudinally
oriented myocardial fibers, the atrioventricular plane is
pulled towards the apex of the heart. This will cause
stretching of the LA, augmenting filling of the atrium.
LV active relaxation starts in late systole, which
together with elastic recoil results in rapid early ven-
tricular filling and return of the atrioventricular plane
to the resting level. Consequently, the LA will rapidly
return to a smaller volume during early LV filling.
With subsequent diastasis, there is no wall motion,
and the atrium and the ventricle form a single cham-
ber with equalization of LA and LV diastolic pres-
sures. During this phase, almost no changes in LA
volume will occur. Only during the final portion of
ventricular diastole, atrial systole generates energy with
contraction and subsequent additional LV filling. On
the basis of this, LAEF will reflect the difference in
LA volume from the volume at the end of diastasis
and at the end of atrial contraction relative to diastasis
volume. The diastasis volume is, as discussed, depen-
Table 3. Univariate and Adjusted LA Predictors of All-Cause Mo
SD Univariate HR 95
LA maximal volume, ml/m2 11 1.27 0.9
LA minimal volume, ml/m2 11 1.61 1.2
Fractional change, % 10 0.47 0.3
Cyclic change, ml/m2 6 0.46 0.3
LA ejection fraction, % 9 0.47 0.3
LA stroke volume, ml/m2 4 0.55 0.3
Adjustments were made for age, left ventricular ejection fraction, Killip class, a
Abbreviations as in Table 2.dent on LV diastolic pressure and LV function,whereas LAmin is determined by a combination of
intrinsic LA contractility and the load the LA faces
(LV effective chamber compliance and retrograde flow
into the pulmonary veins determined by pulmonary
venous capacitance). Finally, fractional change, which
describes the maximal change in LA volumes relative to
LAmax, can be regarded as the sum of the numerous
intrinsic ventricular and atrial properties discussed.
Despite this complexity, the clinical relevance of
the LA imaging has been derived almost exclusively
from measurements of LAmax or merely maximal
diameter assessed by 2-dimensional or M-mode
echocardiography. Clearly, this may not encom-
pass the full potential of prognostic information
of the LA.
In agreement, the present study demonstrates
that impaired LA function with reduced fractional
change and LAEF were independent predictors of
mortality in low-risk patients with NSTEMI after
adjustment for known risk factors. Moreover, the
Figure 3. Receiver-Operator Characteristic Curves
Receiver-operator characteristic curves for fractional change, left atr
ejection fraction, and left atrial maximal volume, demonstrating the
ity According to Standard Deviations of the LA Variables
I p Value Adjusted HR 95% CI p Value
71 0.120 1.06 0.76–1.47 0.53
04 0.001 1.31 0.96–1.79 0.08
62 0.001 0.65 0.45–0.94 0.02
65 0.001 0.68 0.47–0.98 0.04
63 0.001 0.63 0.44–0.91 0.01
80 0.001 0.64 0.44–0.92 0.02
umber of diseased coronary vessels.ialrtal
% C
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1086prognostic significance of fractional change and
LAEF contained incremental value to LAmax.
The pathophysiological link between reduced LA
function and adverse clinical outcome cannot be di-
rectly elucidated from the present study. However, in
a previous study, Torabi et al. (12) found in a consec-
utive population of 896 patients that 84% of deaths
occurring during follow-up were preceded by heart
failure at some point. The development of symptom-
atic heart failure (shortness of breath on exertion) in
patients with NSTEMI requires LV filling pressures
to be elevated; the cause of this may be a complex
interplay of multiple factors including myocardial
ischemia, neurohormonal activation, renal failure, left
ventricular remodeling, hypertrophy, and pre-existing
decrease of effective chamber compliance. All of these
factors would be anticipated to affect atrial size and
contraction. The present results and the results of a
previous hypothesis-generating study (8), where we
ound that clinical signs of heart failure are associated
ith impaired LA mechanical function (fractional
hange and LAEF) to a greater extent than
Amax, concur with this theory. Impaired LA
unction could perhaps be interpreted as an early
orphological manifestation for increased risk of
eveloping heart failure and, eventually, death.
hus, although it is speculative, we believe that
mpaired LA function is a risk factor for the
evelopment of heart failure and that this could
rovide the link to poor prognosis.
Regardless of the mechanism responsible for the
redictive value of LA functional imaging, an im-
roved prognostic evaluation could be clinically
seful. Further studies are needed to explore the
otential clinical benefits of LA functional imaging.
In the present study, LAmax was only a weak
redictor of outcome as opposed to previous studies
here LAmax on echocardiography has been re-
orted to be an important predictor of outcome.
lthough the present study provides no direct
nsight into this discrepancy, it could likely be
aused by different risk profiles in study popula-
ions. Patients with increased risk due to renal
ysfunction, hemodynamic instability, and so on
ere excluded from the present study, leaving a
opulation with a considerably lower risk profile and
n a priori lower likelihood of presenting with an
nlarged LA than previous echocardiographic studies.
ossibly this explains that LAmax is less potent in the
resent study in predicting outcome. In addition,
ifferences in defining LA volume on echocardiogra-
hy and MDCT may have influenced the results. pStudy limitations. In the present study, patients at
he highest risk were not enrolled, thus the study
escribes a low-risk group without cardiac arrhyth-
ias or renal dysfunction suitable for MDCT
canning. Accordingly, the present results may not
e generalized to the average NSTEMI population.
owever, this may emphasize 2 important points.
irst, it may explain that we do not find a significant
elation between LAmax and survival. LAmax has
reviously been shown to be a powerful predictor in
yocardial infarction patients with more comorbid-
ty and higher mortality rates (4,5). Second, this
eems to emphasize that LA functional values are
ensitive predictors of mortality.
To measure LA size and function, we used retro-
pectively gated MDCT scanning. MDCT has high
patial resolution, but lower temporal resolution than
agnetic resonance imaging and echocardiography,
hich could affect the precision of MDCT. However,
everal studies have consistently demonstrated very
ood agreement and correlation between MDCT and
agnetic resonance imaging, and good correlation
etween MDCT and echocardiography when mea-
uring LA size and function (13–17).
In contemporary clinical cardiac MDCT imaging
mplementing prospective data acquisition, the use
f retrospective gating is limited because of the
elatively high radiation exposure. Accordingly,
unctional information may not be routinely avail-
ble in future MDCT examinations of low-risk
atients. LA size and functional values, however,
ay be assessed accurately with both magnetic
esonance imaging (18) and promisingly also with
- and 3-dimensional echocardiography (19–21).
Echocardiography was performed at referring
ospitals, and not according to a specific protocol,
n multiple different ultrasound systems with focus
n assessment of LV systolic function and detection
f left-sided valve disease. However, unfortunately,
o systematic assessments of LV diastolic function
r LAmax were available.
We had four obvious explanatory variables—a
riori known predictors of death, which were sig-
ificant in univariate analysis—for a multivariable
egression model: age, Killip class, LVEF, and
umber of diseased vessels. This number of vari-
bles is in the higher end of what is statistically
easonable with 35 events, and the results of the
ultivariable analysis should be interpreted with
ppropriate caution. The low number of events
revented us from including other interesting vari-
bles in the models, which may have decreased the
rognostic utility of the LA variables.
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The present study demonstrates that impaired LA
function in terms of reduced LA fractional change
and LAEF predict a poor prognosis in low-risk
patients with NSTEMI, even after adjustment for
conventional risk factors. Furthermore, the prog-
nostic significance of fractional change and LAEF
contained incremental value to LAmax. Measure-
ment of LA function could serve as a sensitive tool
for early risk stratification in apparently low-risk
patients with NSTEMI. Further studies should
reproduce these results in other patient categoriesmechanical function in ischemic heart
1
1
1
1
1
1
ography: validationpatients that we may be able to risk-stratify with
this method, preferably also using echocardiography
or magnetic resonance imaging.
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